Disproportionality signals for IGE All five GLP-1RAs had statistically significant reporting odds ratios (RORs) for IGE: Semaglutide: ROR 24.8 Dulaglutide: ROR 14.7 Liraglutide: ROR 13.7 Exenatide: ROR 5.4 Tirzepatide: ROR 18.3 This analysis confirms that these drugs are significantly more likely to be reported in conjunction with IGE compared to other medications
In the mITT population, the average change in the number of SSEs from baseline to the end of the study was +0.7 events per month in the pooled groups receiving 1.25 and 1.75 mg doses of BMT, compared to only +0.2 events in the placebo group
Patrick Carroll, Chief Medical Officer of Hims & Hers
AOD-9604 Molecular Formula AOD-9604 is a 16-amino-acid peptide with a disulfide bridge and the molecular formula C78H123N23O23S2 , with a molecular weight of approximately 1815.1 daltons
Some symptoms may begin to improve within two weeks, while improvement can take up to three months or longer for some people
measure progress in strength gains or with tape measures